Jonathan A. Stefely

Jonathan A. Stefely

Auto-generated profile, based on publicly available information

Jonathan A. Stefely

Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
JSJonathan A. Stefely
Jonathan A. Stefely
DPDavid J. Pagliarini
David J. Pagliarini

1 August 2016 in Molecular Cell
Verified
Journal Article
Closed access
Brendan FloydBrendan Floyd
Brendan Floyd
EWEmily M. Wilkerson
Emily M. Wilkerson
MVMike T. Veling
Mike T. Veling
CMCatie E. Minogue
Catie E. Minogue
CXChuanwu Xia
Chuanwu Xia
DPDavid J. Pagliarini
David J. Pagliarini

1 August 2016 in Molecular Cell
Verified
Journal Article
Closed access
JSJonathan A. Stefely
Jonathan A. Stefely
FLFloriana Licitra
Floriana Licitra
LLLeila Laredj
Leila Laredj
ARAndrew G. Reidenbach
Andrew G. Reidenbach
ZKZachary A. Kemmerer
Zachary A. Kemmerer
DPDavid J. Pagliarini
David J. Pagliarini

22 October 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DLDanielle C. Lohman
Danielle C. Lohman
FFFarhad Forouhar
Farhad Forouhar
EBEmily T. Beebe
Emily T. Beebe
MSMatthew S. Stefely
Matthew S. Stefely
CMCatherine E. Minogue
Catherine E. Minogue
DPDavid J. Pagliarini
David J. Pagliarini
Coenzyme Q (CoQ) is an isoprenylated quinone that is essential for cellular respiration and is synthesized in mitochondria by the combined action of at least nine proteins (COQ1–9). Although most COQ proteins are known to catalyze modifications to CoQ precursors, the biochemical role of COQ9 remains unclear. Here, we report that a disease-related COQ9 mutation leads to extensive disruption of the CoQ protein biosynthetic complex in a mouse model, and that COQ9 specifically interacts with COQ7 through a series of conserved residues. Toward understanding how COQ9 can perform these functions, we solved the crystal structure of Homo sapiens COQ9 at 2.4 Å. Unexpectedly, our structure reveals that COQ9 has structural homology to the TFR family of bacterial transcriptional regulators, but that it adopts an atypical TFR dimer orientation and is not predicted to bind DNA. Our structure also reveals a lipid-binding site, and mass spectrometry-based analyses of purified COQ9 demonstrate that it associates with multiple lipid species, including CoQ itself. The conserved COQ9 residues necessary for its interaction with COQ7 comprise a surface patch around the lipid-binding site, suggesting that COQ9 might serve to present its bound lipid to COQ7. Collectively, our data define COQ9 as the first, to our knowledge, mammalian TFR structural homolog and suggest that its lipid-binding capacity and association with COQ7 are key features for enabling CoQ biosynthesis. Significance Coenzyme Q (CoQ) is a requisite component of the mitochondrial oxidative phosphorylation machinery that produces more than 90% of cellular ATP. Despite the discovery of CoQ more than 50 years ago, many aspects of its biosynthesis remain obscure. These include the functions of uncharacterized CoQ-related proteins whose disruption can cause human diseases. Our work reveals that one such protein, COQ9, is a lipid-binding protein that enables CoQ biosynthesis through its physical and functional interaction with COQ7, and via its stabilization of the entire CoQ biosynthetic complex. Unexpectedly, COQ9 achieves these functions by repurposing an ancient bacterial fold typically used for transcriptional regulation. Collectively, our work adds new insight into a core component of the CoQ biosynthesis process.

26 September 2016 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
JSJonathan A Stefely
Jonathan A Stefely
NKNicholas W Kwiecien
Nicholas W Kwiecien
EFElyse C Freiberger
Elyse C Freiberger
ARAlicia L Richards
Alicia L Richards
AJAdam Jochem
Adam Jochem
JCJoshua J Coon
Joshua J Coon
Proteomics, lipidomics and metabolomics of single gene deletion yeast strains sheds light on mitochondrial protein biology. Mitochondrial dysfunction is associated with many human diseases, including cancer and neurodegeneration, that are often linked to proteins and pathways that are not well-characterized. To begin defining the functions of such poorly characterized proteins, we used mass spectrometry to map the proteomes, lipidomes, and metabolomes of 174 yeast strains, each lacking a single gene related to mitochondrial biology. 144 of these genes have human homologs, 60 of which are associated with disease and 39 of which are uncharacterized. We present a multi-omic data analysis and visualization tool that we use to find covariance networks that can predict molecular functions, correlations between profiles of related gene deletions, gene-specific perturbations that reflect protein functions, and a global respiration deficiency response. Using this multi-omic approach, we link seven proteins including Hfd1p and its human homolog ALDH3A1 to mitochondrial coenzyme Q (CoQ) biosynthesis, an essential pathway disrupted in many human diseases. This Resource should provide molecular insights into mitochondrial protein functions.

1 January 2015 in Molecular Cell
Verified
Journal Article
Closed access
JSJonathan A. Stefely
Jonathan A. Stefely
ARAndrew G. Reidenbach
Andrew G. Reidenbach
AUArne Ulbrich
Arne Ulbrich
KOKrishnadev Oruganty
Krishnadev Oruganty
Brendan FloydBrendan Floyd
Brendan Floyd
DPDavid J. Pagliarini
David J. Pagliarini